Details of the Drug
General Information of Drug (ID: DML5PE9)
| Drug Name |
2-methoxyphenylboronic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-Methoxyphenylboronic acid; 5720-06-9; 2-Methoxybenzeneboronic acid; (2-methoxyphenyl)boronic Acid; 2-methoxyphenyl boronic acid; o-Methoxyphenylboronic acid; 2-boronoanisole; (2-methoxyphenyl)boranediol; MFCD00236047; o-methoxyphenyl boronic acid; 2-methoxy phenylboronic acid; 2-methoxybenzene boronic acid; Boronic acid, (2-methoxyphenyl)-; 2-methoxypenylboronic acid; 2-Methoxybenzeneboronicacid; PubChem1865; ACMC-1AZDE; 2-methoxypbenylboronic acid; AC1Q44YL; AC1MC01Q; 2-methyoxyphenylboronic acid; 2-methoxyphenyl-boronic aci
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 151.96 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


